Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 22, 2018

DrugPatentWatch Database Preview

Teligent Company Profile

« Back to Dashboard

What is the competitive landscape for TELIGENT, and what generic and branded alternatives to TELIGENT drugs are available?

TELIGENT has forty-four approved drugs.

Summary for Teligent

US Patents:	0
Tradenames:	36
Ingredients:	31
NDAs:	44
Patent Litigation for Teligent:	See patent lawsuits for Teligent

Drugs and US Patents for Teligent

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teligent	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	018656-001	Jun 28, 1983		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Teligent Pharma Inc	DESOXIMETASONE	desoximetasone	OINTMENT;TOPICAL	208101-001	Feb 25, 2016	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Teligent Pharma Inc	HYDROCORTISONE BUTYRATE	hydrocortisone butyrate	LOTION;TOPICAL	209556-001	Nov 21, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Teligent	CIPROFLOXACIN HYDROCHLORIDE	ciprofloxacin hydrochloride	SOLUTION/DROPS;OPHTHALMIC	076754-001	Jun 9, 2004	AT	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Teligent

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teligent	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,128,659	➤ Try a Free Trial
Teligent	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,521,431*PED	➤ Try a Free Trial
Teligent	ZANTAC	ranitidine hydrochloride	INJECTABLE;INJECTION	019090-001	Oct 19, 1984	4,128,658	➤ Try a Free Trial
Teligent	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,585,790*PED	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo

Cipla

Mallinckrodt

Healthtrust

QuintilesIMS

Julphar

Queensland Health

Johnson and Johnson

Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.